An overview of the role of the gut microbiota in rheumatoid arthritis

Abstract

Rheumatoid arthritis (RA) is a chronic autoimmune disease preceded by a prolonged preclinical phase marked by the emergence of autoantibodies and mucosal immune dysregulation. Evidence from human studies and animal models consistently demonstrates that gut microbiota dysbiosis contributes to this transition, particularly through impaired intestinal barrier function, activation of pro-inflammatory pathways, and molecular mimicry. Specific taxa - including Prevotella copri, Collinsella aerofaciens, and reductions in butyrate-producing bacteria - have been linked to heightened systemic inflammation, increased T helper 17 responses, and the generation of RA-associated autoantibodies. Current research also indicates that anti-rheumatic medications such as methotrexate, sulfasalazine, and minocycline produce measurable shifts in gut microbial composition, suggesting that microbiota-drug interactions may influence treatment response. Therapeutic approaches aimed at modifying gut ecology - including dietary interventions, prebiotics, probiotics, and fecal microbiota transplantation - show early potential in restoring microbial balance, improving intestinal barrier integrity, and reducing inflammatory markers, although evidence in the preclinical RA stage remains limited. Additionally, emerging data highlight the importance of intestinal autophagy and microRNA networks in regulating epithelial integrity and systemic immune activation. Taken together, the literature supports a mechanistic link between gut dysbiosis and the onset of RA. It points to microbiota-targeted strategies as promising avenues for delaying or preventing disease progression. Future studies should prioritize longitudinal analyses and interventional trials focusing specifically on individuals at risk for RA.

Keywords

Rheumatoid arthritis / autoimmunity / inflammation / microbiome

References

[1] Lin YJ,Anzaghe M,Schülke S. Update on the pathomechanism, diagnosis, and treatment options for rheumatoid arthritis Cells 2020 9 880 PMC7226834

[2] Amaya-Amaya J,Rojas-Villarraga A,Mantilla RD.et al. Rheumatoid arthritis. In: Anaya JM, Shoenfeld Y, Rojas-Villarraga A, et al., editors. Autoimmunity: From Bench to Bedside. Bogota (Colombia): El Rosario University Press; 2013. Chapter 24

[3] Bullock J,Rizvi SAA,Saleh AM.et al. Rheumatoid arthritis: a brief overview of the treatment Med Princ Pract 2018 27 501 7 PMC6422329

[4] Radu AF,Bungau SG. Management of rheumatoid arthritis: an overview Cells 2021 10 2857 PMC8616326

[5] Ben Mrid R,Bouchmaa N,Ainani H,El Fatimy R,Malka G,Mazini L. Anti-rheumatoid drugs advancements: new insights into the molecular treatment of rheumatoid arthritis Biomed Pharmacother 2022 151 113126

[6] Haschka J,Englbrecht M,Huebe A.et al. Relapse rates in patients with rheumatoid arthritis in stable remission tapering or stopping antirheumatic therapy: interim results from the prospective randomised controlled RETRO study Ann Rheum Dis 2016 75 45 51

[7] Frazzei G,Musters A,de Vries N,Tas SW,van Vollenhoven RF. Prevention of rheumatoid arthritis: a systematic literature review of preventive strategies in at-risk individuals Autoimmun Rev 2023 22 103217

[8] Wang Z,Huang J,Xie D,He D,Lu A,Liang C. Toward overcoming treatment failure in rheumatoid arthritis Front Immunol 2021 12 755844 PMC8732378

[9] Fanouriakis A,Kostopoulou M,Andersen J.et al. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update Ann Rheum Dis 2024 83 15 29

[10] Khader Y,Beran A,Ghazaleh S,Lee-Smith W,Altorok N. Predictors of remission in rheumatoid arthritis patients treated with biologics: a systematic review and meta-analysis Clin Rheumatol 2022 41 3615 27 PMC9652218

[11] Ajeganova S,Huizinga T. Sustained remission in rheumatoid arthritis: latest evidence and clinical considerations Ther Adv Musculoskelet Dis 2017 9 249 62 PMC5613855

[12] Deane KD,Norris JM,Holers VM. Preclinical rheumatoid arthritis: identification, evaluation, and future directions for investigation Rheum Dis Clin North Am 2010 36 213 41 PMC2879710

[13] Sokolova MV,Schett G,Steffen U. Autoantibodies in rheumatoid arthritis: historical background and novel findings Clin Rev Allergy Immunol 2022 63 138 51 PMC9464122

[14] Holers VM,Demoruelle KM,Buckner JH.et al. Distinct mucosal endotypes as initiators and drivers of rheumatoid arthritis Nat Rev Rheumatol 2024 20 601 13 PMC12573308

[15] Sanmartí R,Frade-Sosa B,Ponce A. The so-called pre-clinical rheumatoid arthritis: doubts, challenges, and opportunities J Clin Med 2024 13 6387 PMC11546573

[16] Jiao Y,Wu L,Huntington ND,Zhang X. Crosstalk between gut microbiota and innate immunity and its implication in autoimmune diseases Front Immunol 2020 11 282 PMC7047319

[17] De Luca F,Shoenfeld Y. The microbiome in autoimmune diseases Clin Exp Immunol 2019 195 74 85 PMC6300652

[18] Lin L,Zhang K,Xiong Q.et al. Gut microbiota in pre-clinical rheumatoid arthritis: From pathogenesis to preventing progression J Autoimmun 2023 141 103001

[19] Fan J,Jiang T,He D. Advances in the implications of the gut microbiota on the treatment efficacy of disease-modifying anti-rheumatic drugs in rheumatoid arthritis Front Immunol 2023 14 1189036 PMC10568326

[20] Wells PM,Williams FMK,Matey-Hernandez ML,Menni C,Steves CJ. 'RA and the microbiome: do host genetic factors provide the link? J Autoimmun 2019;99:104-15 PMC6470121

[21] Malczewski AB,Coward JI,Ketheesan N,Navarro S. Immunometabolism: the role of gut-derived microbial metabolites in optimising immune response during checkpoint inhibitor therapy Clin Transl Med 2025 15 e70472 PMC12411929

[22] Romero-Figueroa MDS,Ramírez-Durán N,Montiel-Jarquín AJ,Horta-Baas G. Gut-joint axis: gut dysbiosis can contribute to the onset of rheumatoid arthritis via multiple pathways Front Cell Infect Microbiol 2023 13 1092118 PMC9911673

[23] Longo UG,Lalli A,Bandini B.et al. Role of the gut microbiota in osteoarthritis, rheumatoid arthritis, and spondylarthritis: an update on the gut-joint axis Int J Mol Sci 2024 25 3242 PMC10970477

[24] Arya P,Sharma V,Singh P,Thapliyal S,Sharma M. Bacterial endotoxin-lipopolysaccharide role in inflammatory diseases: an overview Iran J Basic Med Sci 2025 28 553 64 PMC12258786

[25] Farhana A,Khan YS. Biochemistry, Lipopolysaccharide. [Updated 2023 Apr 17]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available online: https://www.ncbi.nlm.nih.gov/books/NBK554414/. [Last accessed 24 February 2026]

[26] An L,Wirth U,Koch D.et al. The Role of Gut-derived lipopolysaccharides and the intestinal barrier in fatty liver diseases J Gastrointest Surg 2022 26 671 83 PMC8926958

[27] Lin TL,Shu CC,Chen YM.et al. Like cures like: pharmacological activity of anti-inflammatory lipopolysaccharides from gut microbiome Front Pharmacol 2020 11 554 PMC7212368

[28] Mahroum N,Seida R,Shoenfeld Y. Triggers and regulation: the gut microbiome in rheumatoid arthritis Expert Rev Clin Immunol 2023 19 1449 56

[29] Reyes-Castillo Z,Valdés-Miramontes E,Llamas-Covarrubias M,Muñoz-Valle JF. Troublesome friends within us: the role of gut microbiota on rheumatoid arthritis etiopathogenesis and its clinical and therapeutic relevance Clin Exp Med 2021 21 1 13

[30] Balasundaram D,Veerasamy V,Sylvia Singarayar M,Neethirajan V,Ananth Devanesan A,Thilagar S. Therapeutic potential of probiotics in gut microbial homeostasis and Rheumatoid arthritis Int Immunopharmacol 2024 137 112501

[31] Greenblatt HK,Kim HA,Bettner LF,Deane KD. Preclinical rheumatoid arthritis and rheumatoid arthritis prevention Curr Opin Rheumatol 2020 32 289 96 PMC7340337

[32] Romão VC,Fonseca JE. Disease mechanisms in preclinical rheumatoid arthritis: a narrative review Front Med (Lausanne) 2022 9 689711 PMC9437632

[33] Cope AP,Jasenecova M,Vasconcelos JC.et al. APIPPRA study investigators Abatacept in individuals at high risk of rheumatoid arthritis (APIPPRA): a randomised, double-blind, multicentre, parallel, placebo-controlled, phase 2b clinical trial Lancet 2024 403 838 49 PMC6633323

[34] Tsetseri MN,Silman AJ,Keene DJ,Dakin SG. The role of the microbiome in rheumatoid arthritis: a review Rheumatol Adv Pract 2023 7 rkad034 PMC11007908

[35] Coradduzza D,Bo M,Congiargiu A.et al. Decoding the microbiome’s influence on rheumatoid arthritis Microorganisms 2023 11 2170 PMC10536067

[36] Alpízar-Rodríguez D,Finckh A,Gilbert B. The role of nutritional factors and intestinal microbiota in rheumatoid arthritis development Nutrients 2020 13 96 PMC7823566

[37] Nii T,Maeda Y,Motooka D.et al. Genomic repertoires linked with pathogenic potency of arthritogenic Prevotella copri isolated from the gut of patients with rheumatoid arthritis Ann Rheum Dis 2023 82 621 9 PMC10176341

[38] Rooney CM,Mankia K,Emery P. The role of the microbiome in driving RA-related autoimmunity Front Cell Dev Biol 2020 8 538130 PMC7550627

[39] Poznyak AV,Kashirskikh DA,Postnov AY,Popov MA,Sukhorukov VN,Orekhov AN. Sialic acid as the potential link between lipid metabolism and inflammation in the pathogenesis of atherosclerosis Braz J Med Biol Res 2023 56 e12972

[40] Maeda Y,Takeda K. Host-microbiota interactions in rheumatoid arthritis Exp Mol Med 2019 51 1 6 PMC6906371

[41] Koh JH,Lee EH,Cha KH,Pan CH,Kim D,Kim WU. Factors associated with the composition of the gut microbiome in patients with established rheumatoid arthritis and its value for predicting treatment responses Arthritis Res Ther 2023 25 32 PMC9979421

[42] Rogier R,Ederveen THA,Boekhorst J.et al. Aberrant intestinal microbiota due to IL-1 receptor antagonist deficiency promotes IL-17- and TLR4-dependent arthritis Microbiome 2017 5 63 PMC5481968

[43] Pianta A,Arvikar S,Strle K.et al. Evidence of the immune relevance of Prevotella copri, a gut microbe, in patients with rheumatoid arthritis Arthritis Rheumatol 2017 69 964 75 PMC5406252

[44] Zheng D,Liwinski T,Elinav E. Interaction between microbiota and immunity in health and disease Cell Res 2020 30 492 506 PMC7264227

[45] Seifert JA,Bemis EA,Ramsden K.et al. Association of antibodies to Prevotella copri in anti-cyclic citrullinated peptide-positive individuals at risk of developing rheumatoid arthritis and in patients with early or established rheumatoid arthritis Arthritis Rheumatol 2023 75 507 16 PMC10065886

[46] Wei F,Zhao M,Sun X,Ma H,Yin H,Shen X. Causal associations between gut microbiota and rheumatoid arthritis: a two-sample Mendelian randomization study Medicine (Baltimore) 2025 104 e42596

[47] Horta-Baas G,Romero-Figueroa MDS,Montiel-Jarquín AJ,Pizano-Zárate ML,García-Mena J,Ramírez-Durán N. Intestinal dysbiosis and rheumatoid arthritis: a link between gut microbiota and the pathogenesis of rheumatoid arthritis J Immunol Res 2017 2017 4835189 PMC5602494

[48] Zhao T,Wei Y,Zhu Y.et al. Gut microbiota and rheumatoid arthritis: from pathogenesis to novel therapeutic opportunities Front Immunol 2022 13 1007165 PMC9499173

[49] Marietta EV,Murray JA,Luckey DH.et al. Suppression of inflammatory arthritis by human gut-derived Prevotella histicola in humanized mice Arthritis Rheumatol 2016 68 2878 88 PMC5125894

[50] Larsen JM. The immune response to Prevotella bacteria in chronic inflammatory disease Immunology 2017 151 363 74 PMC5506432

[51] Balakrishnan B,Luckey D,Bodhke R.et al. Prevotella histicola protects from arthritis by expansion of allobaculum and augmenting butyrate production in humanized mice Front Immunol 2021 12 609644 PMC8130672

[52] Zang X,Xiao M,Yu L.et al. Prevotella copri - a potential next-generation probiotic Food Frontiers 2024 5 1391 409

[53] Hayase E,Jenq RR. Role of the intestinal microbiome and microbial-derived metabolites in immune checkpoint blockade immunotherapy of cancer Genome Med 2021 13 107 PMC8220726

[54] Rooney CM,Jeffery IB,Mankia K,Wilcox MH,Emery P. Dynamics of the gut microbiome in individuals at risk of rheumatoid arthritis: a cross-sectional and longitudinal observational study Ann Rheum Dis 2024 84 562 74

[55] Roszyk E,Puszczewicz M. Role of human microbiome and selected bacterial infections in the pathogenesis of rheumatoid arthritis Reumatologia 2017 55 242 50 PMC5746635

[56] Zhao Q,Chen Y,Huang W,Zhou H,Zhang W. Drug-microbiota interactions: an emerging priority for precision medicine Signal Transduct Target Ther 2023 8 386 PMC10560686

[57] Zádori ZS,Király K,Al-Khrasani M,Gyires K. Interactions between NSAIDs, opioids and the gut microbiota - future perspectives in the management of inflammation and pain Pharmacol Ther 2023 241 108327

[58] Hao Y. Gut microbiota-immune axis in the regulation of rheumatoid arthritis: from mechanism to precision probiotic strategies Mod Rheumatol 2025 36 1 14

[59] Hellwig M,Diel P,Eisenbrand G.et al. Dietary glycation compounds - implications for human health Crit Rev Toxicol 2024 54 485 617

[60] Phuong-Nguyen K,McNeill BA,Aston-Mourney K,Rivera LR. Advanced glycation end-products and their effects on gut health Nutrients 2023 15 405 PMC9867518

[61] Shoham S,Pintel N,Avni D. Oxidative stress, gut bacteria, and microalgae: a holistic approach to manage inflammatory bowel diseases Antioxidants (Basel) 2025 14 697 PMC12189200

[62] Ma Z,Zuo T,Frey N,Rangrez AY. A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation Signal Transduct Target Ther 2024 9 237 PMC11418828

[63] Aggarwal N,Kitano S,Puah GRY,Kittelmann S,Hwang IY,Chang MW. Microbiome and human health: current understanding, engineering, and enabling technologies Chem Rev 2023 123 31 72 PMC9837825

[64] Wu IW,Lin CY,Chang LC.et al. Gut microbiota as diagnostic tools for mirroring disease progression and circulating nephrotoxin levels in chronic kidney disease: discovery and validation study Int J Biol Sci 2020 16 420 34 PMC6990903

[65] You Y,Xiang T,Yang C.et al. Interactions between the gut microbiota and immune cell dynamics: novel insights into the gut-bone axis Gut Microbes 2025 17 2545417 PMC12396131

[66] Ortega MA,Álvarez-Mon MA,García-Montero C.et al. Microbiota-gut-brain axis mechanisms in the complex network of bipolar disorders: potential clinical implications and translational opportunities Mol Psychiatry 2023 28 2645 73 PMC10615769

[67] Xie X,Chen X,Wang X,Wang S,Qi P. Dual regulatory effects of gut microbiota and their metabolites in rheumatoid arthritis: balancing pathogenic and protective mechanisms Front Immunol 2025 16 1584023 PMC12075411

[68] Gargari G,Mantegazza G,Cremon C.et al. Collinsella aerofaciens as a predictive marker of response to probiotic treatment in non-constipated irritable bowel syndrome Gut Microbes 2024 16 2298246 PMC10773624

[69] Chen J,Wright K,Davis JM.et al. An expansion of rare lineage intestinal microbes characterizes rheumatoid arthritis Genome Med 2016 8 43 PMC4840970

[70] Korzeniowska A,Bryl E. Infectious and commensal bacteria in rheumatoid arthritis-role in the outset and progression of the disease Int J Mol Sci 2024 25 3386 PMC10970214

[71] Romano S,Wirbel J,Ansorge R.et al. Machine learning-based meta-analysis reveals gut microbiome alterations associated with Parkinson’s disease Nat Commun 2025 16 4227 PMC12059030

[72] Vandeputte D,Kathagen G,D’hoe K.et al. Quantitative microbiome profiling links gut community variation to microbial load Nature 2017 551 507 11

[73] Knight R,Vrbanac A,Taylor BC.et al. Best practices for analysing microbiomes Nat Rev Microbiol 2018 16 410 22

[74] Gloor GB,Macklaim JM,Pawlowsky-Glahn V,Egozcue JJ. Microbiome Datasets are compositional: and this is not optional Front Microbiol 2017 8 2224 PMC5695134

[75] Juárez-Chairez MF,Cid-Gallegos MS,Jiménez-Martínez C,Prieto-Contreras LF,Bollain-Y-Goytia de-la-Rosa JJ. The role of microbiota on rheumatoid arthritis onset Int J Rheum Dis 2024 27 e15122

[76] Wagner S,Weber M,Paul LS.et al. Absolute abundance calculation enhances the significance of microbiome data in antibiotic treatment studies Front Microbiol 2025 16 1481197 PMC11973300

[77] Guo C,Che X,Briese T.et al. Deficient butyrate-producing capacity in the gut microbiome is associated with bacterial network disturbances and fatigue symptoms in ME/CFS Cell Host Microbe 2023 31 288 304.e8 PMC10183837

[78] Liu Z,Wu Y,Luo Y.et al. Self-balance of intestinal flora in spouses of patients with rheumatoid arthritis Front Med (Lausanne) 2020 7 538 PMC7931358

[79] Sadeghpour Heravi, F. Gut microbiota and autoimmune diseases: mechanisms, treatment, challenges, and future recommendations Curr Clin Micro Rpt 2024 11 18 33

[80] Jeong JJ,Park HJ,Cha MG.et al. The lactobacillus as a probiotic: focusing on liver diseases Microorganisms 2022 10 288 PMC8879051

[81] Chen JF,Ou-Yang MC,Hsia KC.et al. A three-arm, randomized, double-blind, placebo-controlled study to evaluate the safety of Lactobacillus salivarius AP-32 and Bifidobacterium animalis CP-9 used individually in healthy infants Nutrients 2023 15 3426 PMC10421338

[82] Yang Y,Hong Q,Zhang X,Liu Z. Rheumatoid arthritis and the intestinal microbiome: probiotics as a potential therapy Front Immunol 2024 15 1331486 PMC10950920

[83] Esvaran M,Conway PL. Lactobacillusfermentum PC1 has the capacity to attenuate joint inflammation in collagen-induced arthritis in DBA/1 mice Nutrients 2019 11 785 PMC6521243

[84] Paul AK,Paul A,Jahan R.et al. Probiotics and amelioration of rheumatoid arthritis: significant roles of Lactobacillus casei and Lactobacillus acidophilus Microorganisms 2021 9 1070 PMC8157104

[85] Fan Z,Ross RP,Stanton C.et al. Lactobacillus casei CCFM1074 alleviates collagen-induced arthritis in rats via balancing Treg/Th17 and modulating the metabolites and gut microbiota Front Immunol 2021 12 680073 PMC8165437

[86] Ferro M,Charneca S,Dourado E,Guerreiro CS,Fonseca JE. Probiotic supplementation for rheumatoid arthritis: a promising adjuvant therapy in the gut microbiome era Front Pharmacol 2021 12 711788 PMC8346200

[87] Bungau SG,Behl T,Singh A.et al. Targeting probiotics in rheumatoid arthritis Nutrients 2021 13 3376 PMC8539185

[88] Rahman SO,Bariguian F,Mobasheri A. The potential role of probiotics in the management of osteoarthritis pain: current status and future prospects Curr Rheumatol Rep 2023 25 307 26 PMC10754743

[89] Thomas S,Izard J,Walsh E.et al. The host microbiome regulates and maintains human health: a primer and perspective for non-microbiologists Cancer Res 2017 77 1783 812

[90] Godha Y,Kumar S,Wanjari A. Role of gut microbiota in the development and management of rheumatoid arthritis: a narrative review Cureus 2023 15 e49458 PMC10751463

[91] Orekhov AN,Summerhill VI,Khotina VA,Popov MA,Uzokov JK,Sukhorukov VN. Role of mitochondria in the chronification of inflammation: focus on dysfunctional mitophagy and mitochondrial DNA mutations. Gene Expr. 2023;22:329-44

[92] Lukas C,Mary J,Debandt M.et al. Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort Arthritis Res Ther 2019 21 243 PMC6858774

[93] Heydari-Kamjani M,Demory Beckler M,Kesselman MM. Reconsidering the use of minocycline in the preliminary treatment regime of rheumatoid arthritis Cureus 2019 11 e5351 PMC6783212

[94] Smith CJ,Sayles H,Mikuls TR,Michaud K. Minocycline and doxycycline therapy in community patients with rheumatoid arthritis: prescribing patterns, patient-level determinants of use, and patient-reported side effects Arthritis Res Ther 2011 13 R168 PMC3308103

[95] Nayak RR. Fanning the flames of autoimmunity: the microbiome in rheumatic disease Arthritis Rheumatol 2022 74 549 52 PMC8957547

[96] Cusumano G,Flores GA,Venanzoni R,Angelini P. The impact of antibiotic therapy on intestinal microbiota: dysbiosis, antibiotic resistance, and restoration strategies Antibiotics (Basel) 2025 14 371 PMC12024230

[97] Scherer HU,Häupl T,Burmester GR. The etiology of rheumatoid arthritis J Autoimmun 2020 110 102400

[98] Xu H,Zhao H,Fan D.et al. Interactions between gut microbiota and immunomodulatory cells in rheumatoid arthritis Mediators Inflamm 2020 2020 1430605 PMC7499318

[99] Koester ST,Chow A,Pepper-Tunick E.et al. Familial clustering of dysbiotic oral and fecal microbiomes in juvenile dermatomyositis Sci Rep 2024 14 16158 PMC11245510

[100] Berthelot JM,Bandiaky ON,Le Goff B.et al. Another look at the contribution of oral microbiota to the pathogenesis of rheumatoid arthritis: a narrative review Microorganisms 2021 10 59 PMC8778040

[101] Danckert NP,Freidin MB,Granville Smith I.et al. Treatment response in rheumatoid arthritis is predicted by the microbiome: a large observational study in UK DMARD-naive patients Rheumatology (Oxford) 2024 63 3486 95 PMC11637416

[102] Volkova A,Ruggles KV. Predictive metagenomic analysis of autoimmune disease identifies robust autoimmunity and disease specific microbial signatures Front Microbiol 2021 12 621310 PMC7969817

[103] Peters BA,Wilson M,Moran U.et al. Relating the gut metagenome and metatranscriptome to immunotherapy responses in melanoma patients Genome Med 2019 11 61 PMC6785875

[104] Nayak RR,Alexander M,Deshpande I.et al. Methotrexate impacts conserved pathways in diverse human gut bacteria leading to decreased host immune activation Cell Host Microbe 2021 29 362 377.e11 PMC7954989

[105] Chen YC,Hou CY,Hsu MH,Huang LT,Hsiao CC,Sheen JM. The impact of gut microbiota changes on methotrexate-induced neurotoxicity in developing young rats Biomedicines 2024 12 908 PMC11048417

[106] Letertre MPM,Munjoma N,Wolfer K.et al. A two-way interaction between methotrexate and the gut microbiota of male Sprague-Dawley rats J Proteome Res 2020 19 3326 39 PMC7426014

[107] Crouwel F,Buiter HJC,de Boer NK. Gut microbiota-driven drug metabolism in inflammatory bowel disease J Crohns Colitis 2021 15 307 15 PMC7904070

[108] Lima SF,Pires S,Rupert A.et al. The gut microbiome regulates the clinical efficacy of sulfasalazine therapy for IBD-associated spondyloarthritis Cell Rep Med 2024 5 101431 PMC10982976

[109] Wang X,Peng J,Cai P.et al. The emerging role of the gut microbiota and its application in inflammatory bowel disease Biomed Pharmacother 2024 179 117302

[110] McIlroy J,Ianiro G,Mukhopadhya I,Hansen R,Hold GL. Review article: the gut microbiome in inflammatory bowel disease-avenues for microbial management Aliment Pharmacol Ther 2018 47 26 42

[111] Zaragoza-García O,Castro-Alarcón N,Pérez-Rubio G,Guzmán-Guzmán IP. DMARDs-gut microbiota feedback: implications in the response to therapy Biomolecules 2020 10 1479 PMC7692063

[112] Zhang L,Chu CQ. Gut microbiota-medication interaction in rheumatic diseases Front Immunol 2021 12 796865 PMC8678121

[113] Bodkhe R,Balakrishnan B,Taneja V. The role of microbiome in rheumatoid arthritis treatment Ther Adv Musculoskelet Dis 2019 11 1759720X19844632 PMC6685117

[114] Cohen I,Ruff WE,Longbrake EE. Influence of immunomodulatory drugs on the gut microbiota Transl Res 2021 233 144 61 PMC8184576

[115] Mei L,Yang Z,Zhang X.et al. Sustained drug treatment alters the gut microbiota in rheumatoid arthritis Front Immunol 2021 12 704089 PMC8551364

[116] Gianchecchi E,Fierabracci A. Recent advances on microbiota involvement in the pathogenesis of autoimmunity Int J Mol Sci 2019 20 283 PMC6359510

[117] Peng J,Lu X,Xie K.et al. Dynamic alterations in the gut microbiota of collagen-induced arthritis rats following the prolonged administration of total glucosides of paeony Front Cell Infect Microbiol 2019 9 204 PMC6581682

[118] Yurtseven B,Aydemir E,Ayaz F. The role of intestinal microbiota and immune system interactions in autoimmune diseases Immunotargets Ther 2025 14 1347 72 PMC12666415

[119] Bhattacharjee P,Karim KA,Khan Z. Harnessing the microbiome: a comprehensive review on advancing therapeutic strategies for rheumatic diseases Cureus 2023 15 e50964 PMC10800157

[120] Oliveira SR,de Arruda JAA,Corrêa JD.et al. Methotrexate and non-surgical periodontal treatment change the oral-gut microbiota in rheumatoid arthritis: a prospective cohort study Microorganisms 2023 12 68 PMC10820502

[121] Anand N,Gorantla VR,Chidambaram SB. The role of gut dysbiosis in the pathophysiology of neuropsychiatric disorders Cells 2022 12 54 PMC9818777

[122] Hou K,Wu ZX,Chen XY.et al. Microbiota in health and diseases Signal Transduct Target Ther 2022 7 135 PMC9034083

[123] Sanchez P,Letarouilly JG,Nguyen Y.et al. Efficacy of probiotics in rheumatoid arthritis and spondyloarthritis: a systematic review and meta-analysis of randomized controlled trials Nutrients 2022 14 354 PMC8779560

[124] Kazemi A,Soltani S,Ghorabi S.et al. Effect of probiotic and synbiotic supplementation on inflammatory markers in health and disease status: a systematic review and meta-analysis of clinical trials Clin Nutr 2020 39 789 819

[125] Li W,Zhang Y,Guo D,Gong R,Yuan J,Yang H. Quality of evidence supporting the role of probiotics for rheumatoid arthritis: an overview of systematic reviews Front Immunol 2024 15 1397716 PMC11169672

[126] Feng J,Pan C,Gou Y.et al. EAT-lancet diet modifies the risk of rheumatoid arthritis through metabolomic signature Arthritis Rheumatol 2026 78 68 79

[127] Zhang W,Mackay CR,Gershwin ME. Immunomodulatory effects of microbiota-derived short-chain fatty acids in autoimmune liver diseases J Immunol 2023 210 1629 39 PMC10188201

[128] Liu XF,Shao JH,Liao YT.et al. Regulation of short-chain fatty acids in the immune system Front Immunol 2023 14 1186892 PMC10196242

[129] Schlatterer K,Peschel A,Kretschmer D. Short-chain fatty acid and FFAR2 activation - a new option for treating infections? Front Cell Infect Microbiol 2021;11:785833 PMC8674814

[130] Chun E,Lavoie S,Fonseca-Pereira D.et al. Metabolite-sensing receptor Ffar2 regulates colonic group 3 innate lymphoid cells and gut immunity Immunity 2019 51 871 884.e6 PMC6901086

[131] Nogal A,Valdes AM,Menni C. The role of short-chain fatty acids in the interplay between gut microbiota and diet in cardio-metabolic health Gut Microbes 2021 13 1 24 PMC8007165

[132] Fusco W,Lorenzo MB,Cintoni M.et al. Short-chain fatty-acid-producing bacteria: key components of the human gut microbiota Nutrients 2023 15 2211 PMC10180739

[133] Tomé-Carneiro J,Visioli F. Plant-based diets reduce blood pressure: a systematic review of recent evidence Curr Hypertens Rep 2023 25 127 50 PMC10224875

[134] Baroni L,Rizzo G,Galchenko AV,Zavoli M,Serventi L,Battino M. Health benefits of vegetarian diets: an insight into the main topics Foods 2024 13 2398 PMC11311397

[135] Pohl A,Schünemann F,Bersiner K,Gehlert S. The impact of vegan and vegetarian diets on physical performance and molecular signaling in skeletal muscle Nutrients 2021 13 3884 PMC8623732

[136] Direito R,Rocha J,Sepodes B,Eduardo-Figueira M. Phenolic compounds impact on rheumatoid arthritis, inflammatory bowel disease and microbiota modulation Pharmaceutics 2021 13 145 PMC7912052

[137] Gál R, Halmosi R, Gallyas F Jr, et al. Resveratrol and beyond: the effect of natural polyphenols on the cardiovascular system: a narrative review Biomedicines 2023 11 2888 PMC10669290

[138] Cione E,La Torre C,Cannataro R,Caroleo MC,Plastina P,Gallelli L. Quercetin, epigallocatechin gallate, curcumin, and resveratrol: from dietary sources to human microrna modulation Molecules 2019 25 63 PMC6983040

[139] Meyer C,Brockmueller A,Ruiz de Porras V,Shakibaei M. Microbiota and resveratrol: how are they linked to osteoporosis? Cells 2024;13:1145 PMC11240679

[140] Wang Y,Hong C,Wu Z.et al. Resveratrol in intestinal health and disease: focusing on intestinal barrier Front Nutr 2022 9 848400 PMC8966610

[141] Lefferts AR,Norman E,Claypool DJ,Kantheti U,Kuhn KA. Cytokine competent gut-joint migratory T cells contribute to inflammation in the joint Front Immunol 2022 13 932393 PMC9489919

[142] Bono MR,Tejon G,Flores-Santibañez F,Fernandez D,Rosemblatt M,Sauma D. retinoic acid as a modulator of T cell immunity Nutrients 2016 8 349 PMC4924190

[143] Jiang Q,Yang G,Liu Q,Wang S,Cui D. Function and role of regulatory T cells in rheumatoid arthritis Front Immunol 2021 12 626193 PMC8047316

[144] Sun H,Kuk W,Rivera-Nieves J,Lopez-Ramirez MA,Eckmann L,Ginsberg MH. β7 Integrin inhibition can increase intestinal inflammation by impairing homing of CD25^hi FoxP3⁺ regulatory T cells Cell Mol Gastroenterol Hepatol 2020 9 369 85 PMC7016000

[145] Rossi B,Dusi S,Angelini G.et al. Alpha4 beta7 integrin controls Th17 cell trafficking in the spinal cord leptomeninges during experimental autoimmune encephalomyelitis Front Immunol 2023 14 1071553 PMC10151683

[146] Song B,Guo W,He Y,Yao X,Sun J,Wang S. Targeting immune cell migration as therapy for inflammatory disease: a review Front Immunol 2025 16 1650760 PMC12507636

[147] Tajik N,Frech M,Schulz O.et al. Targeting Zonulin and intestinal epithelial barrier function to prevent onset of arthritis Nat Commun 2020 11 1995 PMC7181728

[148] Veres-Székely A, Szász C, Pap D, Szebeni B, Bokrossy P, Vannay Á. Zonulin as a potential therapeutic target in microbiota-gut-brain axis disorders: encouraging results and emerging questions Int J Mol Sci 2023 24 7548 PMC10139156

[149] Brandl C,Bucci L,Schett G,Zaiss MM. Crossing the barriers: revisiting the gut feeling in rheumatoid arthritis Eur J Immunol 2021 51 798 810

[150] Shan L,Chelliah R,Rahman SME,Hwan Oh D. Unraveling the gut microbiota’s role in Rheumatoid arthritis: dietary pathways to modulation and therapeutic potential Crit Rev Food Sci Nutr 2025 65 3291 301

[151] Gupta S,Allen-Vercoe E,Petrof EO. Fecal microbiota transplantation: in perspective Therap Adv Gastroenterol 2016 9 229 39 PMC4749851

[152] Arora U,Kedia S,Ahuja V. The practice of fecal microbiota transplantation in inflammatory bowel disease Intest Res 2024 22 44 64 PMC10850701

[153] Ser HL,Letchumanan V,Goh BH,Wong SH,Lee LH. The use of fecal microbiome transplant in treating human diseases: too early for poop? Front Microbiol 2021;12:519836 PMC8155486

[154] Belvoncikova P,Maronek M,Gardlik R. Gut dysbiosis and fecal microbiota transplantation in autoimmune diseases Int J Mol Sci 2022 23 10729 PMC9503867

[155] Hamamah S,Gheorghita R,Lobiuc A,Sirbu IO,Covasa M. Fecal microbiota transplantation in non-communicable diseases: recent advances and protocols Front Med (Lausanne) 2022 9 1060581 PMC9773399

[156] Kragsnaes MS,Kjeldsen J,Horn HC.et al. Safety and efficacy of faecal microbiota transplantation for active peripheral psoriatic arthritis: an exploratory randomised placebo-controlled trial Ann Rheum Dis 2021 80 1158 67

[157] Seida I,Al Shawaf M,Mahroum N. Fecal microbiota transplantation in autoimmune diseases - An extensive paper on a pathogenetic therapy Autoimmun Rev 2024 23 103541

[158] Lu C,Chen J,Yi C.et al. Gut microbiota mediated the protective effects of tuna oil on collagen-induced arthritis in mice Food Funct 2021 12 5387 98

[159] Profir M,Roşu OA,Creţoiu SM,Gaspar BS. Friend or foe: exploring the relationship between the gut microbiota and the pathogenesis and treatment of digestive cancers Microorganisms 2024 12 955 PMC11124004

[160] Ivashkin V,Poluektov Y,Kogan E.et al. Disruption of the pro-inflammatory, anti-inflammatory cytokines and tight junction proteins expression, associated with changes of the composition of the gut microbiota in patients with irritable bowel syndrome PLoS One 2021 16 e0252930 PMC8195381

[161] Bagheri S,Zolghadri S,Stanek A. Beneficial effects of anti-inflammatory diet in modulating gut microbiota and controlling obesity Nutrients 2022 14 3985 PMC9572805

[162] Luo Y,Tong Y,Wu L.et al. Alteration of gut microbiota in individuals at high-risk for rheumatoid arthritis associated with disturbed metabolome and the initiation of arthritis through the triggering of mucosal immunity imbalance Arthritis Rheumatol 2023 75 1736 48

[163] Zeng L,Deng Y,Yang K,Chen J,He Q,Chen H. Safety and efficacy of fecal microbiota transplantation for autoimmune diseases and autoinflammatory diseases: a systematic review and meta-analysis Front Immunol 2022 13 944387 PMC9562921

[164] Cold F,Svensson CK,Petersen AM,Hansen LH,Helms M. Long-term safety following faecal microbiota transplantation as a treatment for recurrent Clostridioides difficile infection compared with patients treated with a fixed bacterial mixture: results from a retrospective cohort study Cells 2022 11 435 PMC8834574

[165] Ooijevaar RE,van Nood E,Goorhuis A.et al. Ten-year follow-up of patients treated with fecal microbiota transplantation for recurrent Clostridioides difficile infection from a randomized controlled trial and review of the literature Microorganisms 2021 9 548 PMC8001384

[166] Quaranta G,Guarnaccia A,Fancello G.et al. Fecal microbiota transplantation and other gut microbiota manipulation strategies Microorganisms 2022 10 2424 PMC9781458

[167] Mitsou EK,Katsagoni CN,Janiszewska K. Knowledge of dietitians on gut microbiota in health-an online survey of the European federation of the associations of dietitians (EFAD) Nutrients 2024 16 621 PMC10935012

[168] Dai Z,Cheng W,Peng H.et al. Microbiota composition-based donor selection affects FMT efficacy in a murine colitis model Front Immunol 2025 16 1635244 PMC12353733

[169] Haq S,Grondin J,Banskota S,Khan WI. Autophagy: roles in intestinal mucosal homeostasis and inflammation J Biomed Sci 2019 26 19 PMC6375151

[170] Zhao J,Duan L,Li J.et al. New insights into the interplay between autophagy, gut microbiota and insulin resistance in metabolic syndrome Biomed Pharmacother 2024 176 116807

[171] Purdel C,Margină D,Adam-Dima I,Ungurianu A. The beneficial effects of dietary interventions on gut microbiota-an up-to-date critical review and future perspectives Nutrients 2023 15 5005 PMC10708505

[172] Mitra S,Munni YA,Dash R.et al. Gut microbiota in autophagy regulation: new therapeutic perspective in neurodegeneration Life (Basel) 2023 13 957 PMC10144697

[173] Niechcial A,Schwarzfischer M,Wawrzyniak M.et al. Spermidine ameliorates colitis via induction of anti-inflammatory macrophages and prevention of intestinal dysbiosis J Crohns Colitis 2023 17 1489 503 PMC10588784

[174] Larabi A,Barnich N,Nguyen HTT. New insights into the interplay between autophagy, gut microbiota and inflammatory responses in IBD Autophagy 2020 16 38 51 PMC6984609

[175] Xuan H,Ou A,Hao S,Shi J,Jin X. Galangin protects against symptoms of dextran sodium sulfate-induced acute colitis by activating autophagy and modulating the gut microbiota Nutrients 2020 12 347 PMC7071155

[176] Fu R,Wang L,Meng Y.et al. Apigenin remodels the gut microbiota to ameliorate ulcerative colitis Front Nutr 2022 9 1062961 PMC9800908

[177] Ermencheva P,Kotov G,Shumnalieva R,Velikova T,Monov S. Exploring the role of the microbiome in rheumatoid arthritis-a critical review Microorganisms 2024 12 1387 PMC11278530

[178] Ghosh S,Whitley CS,Haribabu B,Jala VR. Regulation of intestinal barrier function by microbial metabolites Cell Mol Gastroenterol Hepatol 2021 11 1463 82 PMC8025057

[179] Fu Y,Lyu J,Wang S. The role of intestinal microbes on intestinal barrier function and host immunity from a metabolite perspective Front Immunol 2023 14 1277102 PMC10591221

[180] Engevik MA,Herrmann B,Ruan W.et al. Bifidobacterium dentium-derived y-glutamylcysteine suppresses ER-mediated goblet cell stress and reduces TNBS-driven colonic inflammation Gut Microbes 2021 13 1 21 PMC8128206

[181] Jian H,Liu Y,Wang X,Dong X,Zou X. Akkermansia muciniphila as a next-generation probiotic in modulating human metabolic homeostasis and disease progression: a role mediated by gut-liver-brain axes? Int J Mol Sci 2023;24:3900 PMC9959343

[182] Wang SL,Shao BZ,Zhao SB.et al. Intestinal autophagy links psychosocial stress with gut microbiota to promote inflammatory bowel disease Cell Death Dis 2019 10 391 PMC6766473

[183] Ke P,Shao BZ,Xu ZQ,Chen XW,Liu C. Intestinal autophagy and its pharmacological control in inflammatory bowel disease Front Immunol 2016 7 695 PMC5220102

[184] Lapaquette P,Bizeau JB,Acar N,Bringer MA. Reciprocal interactions between gut microbiota and autophagy World J Gastroenterol 2021 27 8283 301 PMC8717019

[185] Arab HH,Al-Shorbagy MY,Saad MA. Activation of autophagy and suppression of apoptosis by dapagliflozin attenuates experimental inflammatory bowel disease in rats: targeting AMPK/mTOR, HMGB1/RAGE and Nrf2/HO-1 pathways Chem Biol Interact 2021 335 109368

[186] Zhang W,Zou M,Fu J,Xu Y,Zhu Y. Autophagy: A potential target for natural products in the treatment of ulcerative colitis Biomed Pharmacother 2024 176 116891

[187] Buruiană A, Florian ȘI, Florian AI, et al. The roles of miRNA in glioblastoma tumor cell communication: diplomatic and aggressive negotiations Int J Mol Sci 2020 21 1950 PMC7139390

[188] Zhang Y,Yang M,Xie H,Hong F,Yang S. Role of miRNAs in rheumatoid arthritis therapy Cells 2023 12 1749 PMC10340706

[189] Cunningham CC,Wade S,Floudas A.et al. Serum miRNA signature in rheumatoid arthritis and “at-risk individuals” Front Immunol 2021 12 633201 PMC7966707

[190] Kmiołek T,Paradowska-Gorycka A. miRNAs as biomarkers and possible therapeutic strategies in rheumatoid arthritis Cells 2022 11 452 PMC8834522

[191] Datta N,Johnson C,Kao D.et al. MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis Pharmacol Res 2023 194 106870

[192] Gu L,Ren F,Fang X,Yuan L,Liu G,Wang S. Exosomal MicroRNA-181a derived from mesenchymal stem cells improves gut microbiota composition, barrier function, and inflammatory status in an experimental colitis model Front Med (Lausanne) 2021 8 660614 PMC8264068

[193] Yang F,Ni B,Liu Q.et al. Human umbilical cord-derived mesenchymal stem cells ameliorate experimental colitis by normalizing the gut microbiota Stem Cell Res Ther 2022 13 475 PMC9476645

[194] Teng Y,Ren Y,Sayed M.et al. Plant-Derived Exosomal MicroRNAs Shape the Gut Microbiota Cell Host Microbe 2018 24 637 652.e8 PMC6746408

[195] Nikolaieva N,Sevcikova A,Omelka R,Martiniakova M,Mego M,Ciernikova S. Gut microbiota-microRNA interactions in intestinal homeostasis and cancer development Microorganisms 2022 11 107 PMC9867529

[196] Díez-Sainz E,Lorente-Cebrián S,Aranaz P,Riezu-Boj JI,Martínez JA,Milagro FI. Potential mechanisms linking food-derived microRNAs, gut microbiota and intestinal barrier functions in the context of nutrition and human health Front Nutr 2021 8 586564 PMC7985180

[197] Casado-Bedmar M,Viennois E. MicroRNA and gut microbiota: Tiny but mighty-novel insights into their cross-talk in inflammatory bowel disease pathogenesis and therapeutics J Crohns Colitis 2022 16 992 1005 PMC9282881

[198] Li M,Chen WD,Wang YD. The roles of the gut microbiota-miRNA interaction in the host pathophysiology Mol Med 2020 26 101 PMC7648389

[199] Turner JE,Stockinger B,Helmby H. IL-22 mediates goblet cell hyperplasia and worm expulsion in intestinal helminth infection PLoS Pathog 2013 9 e1003698 PMC3795034

[200] Mizoguchi A. Healing of intestinal inflammation by IL-22 Inflamm Bowel Dis 2012 18 1777 84 PMC3366176

[201] Han H,Davidson LA,Fan YY.et al. Loss of aryl hydrocarbon receptor suppresses the response of colonic epithelial cells to IL22 signaling by upregulating SOCS3 Am J Physiol Gastrointest Liver Physiol 2022 322 G93 G106 PMC8714253

[202] Nehmar R,Fauconnier L,Alves-Filho J.et al. Aryl hydrocarbon receptor (Ahr)-dependent Il-22 expression by type 3 innate lymphoid cells control of acute joint inflammation J Cell Mol Med 2021 25 4721 31 PMC8107095

[203] Xiao X,Mao X,Chen D.et al. miRNAs Can affect intestinal epithelial barrier in inflammatory bowel disease Front Immunol 2022 13 868229 PMC9043318

[204] Zhao S,Zhu L,Feng W.et al. MicroRNA-602 prevents the development of inflammatory bowel diseases in a microbiota-dependent manner Exp Ther Med 2021 22 1373 PMC8515559

[205] Kyoko OO,Kono H,Ishimaru K.et al. Expressions of tight junction proteins Occludin and Claudin-1 are under the circadian control in the mouse large intestine: implications in intestinal permeability and susceptibility to colitis PLoS One 2014 9 e98016 PMC4028230

[206] Chen Z,Guan D,Wang Z.et al. Microbiota in cancer: molecular mechanisms and therapeutic interventions MedComm (2020) 2023 4 e417 PMC10626288

[207] Zhao Y,Zeng Y,Zeng D.et al. Probiotics and microRNA: their roles in the host-microbe interactions Front Microbiol 2020 11 604462 PMC7885260

[208] Ionescu RF,Enache RM,Cretoiu SM,Cretoiu D. the interplay between gut microbiota and miRNAs in cardiovascular diseases Front Cardiovasc Med 2022 9 856901 PMC8965857

[209] Zhao LY,Mei JX,Yu G.et al. Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications Signal Transduct Target Ther 2023 8 201 PMC10183032

[210] Di Vincenzo F,Del Gaudio A,Petito V,Lopetuso LR,Scaldaferri F. Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review Intern Emerg Med 2024 19 275 93 PMC10954893

[211] Shao T,Hsu R,Rafizadeh DL.et al. The gut ecosystem and immune tolerance J Autoimmun 2023 141 103114

[212] Dong Y,Yao J,Deng Q.et al. Relationship between gut microbiota and rheumatoid arthritis: a bibliometric analysis Front Immunol 2023 14 1131933 PMC10015446

[213] Lv X,Wang X,Wang X.et al. Research progress in arthritis treatment with the active components of Herba siegesbeckiae Biomed Pharmacother 2023 169 115939

[214] Mitra S,Dash R,Nishan AA,Habiba SU,Moon IS. Brain modulation by the gut microbiota: from disease to therapy J Adv Res 2023 53 153 73 PMC10658262

[215] Schinzari F,Tesauro M,Cardillo C. Vasodilator dysfunction in human obesity: established and emerging mechanisms J Cardiovasc Pharmacol 2021 78 S40 52

[216] Cunningham M,Azcarate-Peril MA,Barnard A.et al. Shaping the future of probiotics and prebiotics Trends Microbiol 2021 29 667 85